Upfront DPD Deficiency Detection to Secure 5-FU Administration: Part 2- Application to Head-and-Neck Cancer Patients

E-ISSN： 2212-6988|4|2|122-128

ISSN： 2212-697x

Source： Clinical Cancer Drugs, Vol.4, Iss.2, 2018-01, pp. : 122-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fluorouracil: Encephalopathy in patients with DPD deficiency: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1283, 2010-01 ,pp. : 42-43

Adis International

Access to resources Recommend Favorite

Management of Head and Neck Cancer in Elderly Patients

By Lalami Yassine

Drugs & Aging, Vol. 26, Iss. 7, 2009-07 ,pp. : 571-583

Adis International

Access to resources Recommend Favorite

Chemotherapy in head and neck cancer

Inpharma, Vol. 1, Iss. 1320, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Micro-RNA Profiling as a Predictor of Clinical Outcomes for Head and Neck Cancer Patients

Current Pharmaceutical Design, Vol. 23, Iss. 32, 2017-12 ,pp. : 4729-4744

Bentham Science Publishers

Access to resources Recommend Favorite

Matrix metalloproteinase-2 as a target for head and neck cancer therapy

By Chien Ming-Hsien Lin Chiao-Wen Cheng Chao-Wen Wen Yu-Ching Yang Shun-Fa

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 2, 2013-02 ,pp. : 203-216

Informa Healthcare

Access to resources Recommend Favorite